These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3134381)

  • 21. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlipidemia. What to do when life-style changes aren't enough.
    Peters WL
    Postgrad Med; 1991 Oct; 90(5):213-7, 220-4. PubMed ID: 1924009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
    Jones PH
    Curr Opin Lipidol; 1995 Dec; 6(6):365-8. PubMed ID: 8750249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.
    Jacobson TA
    Curr Atheroscler Rep; 2001 Sep; 3(5):373-82. PubMed ID: 11487448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hyperlipidaemia.
    Thompson GR
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):337-42. PubMed ID: 8319362
    [No Abstract]   [Full Text] [Related]  

  • 26. [Children and dyslipemia].
    Assmann G; Davignon J; Fernández-Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
    Rev Clin Esp; 1990 Mar; 186(4):178-86. PubMed ID: 2195607
    [No Abstract]   [Full Text] [Related]  

  • 27. GUGULIPID: a natural cholesterol-lowering agent.
    Urizar NL; Moore DD
    Annu Rev Nutr; 2003; 23():303-13. PubMed ID: 12626688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering drugs in the management of hyperlipidaemia.
    Bhatnagar D
    Pharmacol Ther; 1998 Sep; 79(3):205-30. PubMed ID: 9776377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy and clinical trials.
    Ogunko A; Evans M
    Curr Opin Lipidol; 1998 Dec; 9(6):617-8. PubMed ID: 10075483
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent.
    Sirtori CR; Zoppi S; Quarisa B; Agradi E
    Pharmacol Res Commun; 1974 Oct; 6(5):445-56. PubMed ID: 4617230
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid-lowering drugs.
    Milander MM; Kuhn M
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):494-506. PubMed ID: 1576043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinations of drugs in lipid-lowering therapy.
    LaRosa JC
    Am J Med; 1994 May; 96(5):399-400. PubMed ID: 8192169
    [No Abstract]   [Full Text] [Related]  

  • 33. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of hyperlipidaemia.
    Drug Ther Bull; 1996 Dec; 34(12):89-93. PubMed ID: 9018924
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids.
    Butman SM
    Am Heart J; 1991 May; 121(5):1585-90. PubMed ID: 2018001
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary artery disease and diabetes.
    Bohannon NJ
    Postgrad Med; 1999 Feb; 105(2):66-8, 71-2, 77-80. PubMed ID: 10026704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gemfibrozil: new aspects in clinical use].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipid-lowering therapy after an atherosclerotic event.
    Roberts WC
    Am J Cardiol; 1989 Sep; 64(10):693-5. PubMed ID: 2782265
    [No Abstract]   [Full Text] [Related]  

  • 40. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.